S
Shujuan Liu
Researcher at Nanjing University of Posts and Telecommunications
Publications - 236
Citations - 11953
Shujuan Liu is an academic researcher from Nanjing University of Posts and Telecommunications. The author has contributed to research in topics: Phosphorescence & Iridium. The author has an hindex of 52, co-authored 233 publications receiving 8910 citations. Previous affiliations of Shujuan Liu include Fudan University.
Papers
More filters
Journal ArticleDOI
Smart responsive phosphorescent materials for data recording and security protection
Huibin Sun,Shujuan Liu,Wenpeng Lin,Kenneth Yin Zhang,Wen Lv,Xiao Huang,Fengwei Huo,Huiran Yang,Gareth Jenkins,Qiang Zhao,Wei Huang +10 more
TL;DR: The results suggest that rationally designed phosphorescent complexes may be promising candidates for advanced data recording and security protection.
Journal ArticleDOI
Long-Lived Emissive Probes for Time-Resolved Photoluminescence Bioimaging and Biosensing
TL;DR: The design and applications of various kinds of long-lived emissive probes for bioimaging and biosensing via time-resolved photoluminescence techniques are summarized and the imaging contrast and sensing sensitivity are remarkably improved.
Journal ArticleDOI
Polymer‐Based Resistive Memory Materials and Devices
TL;DR: This review introduced the general characteristics of the device structures and fabrication, memory effects, switching mechanisms, and effects of electrodes on memory properties associated with polymer-based resistive memory devices.
Journal ArticleDOI
A Mitochondria‐Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia
Wen Lv,Zhang Zhang,Kenneth Yin Zhang,Huiran Yang,Shujuan Liu,Aqiang Xu,Song Guo,Qiang Zhao,Wei Huang,Wei Huang +9 more
TL;DR: This work designed and synthesized two iridium(III) complexes that specifically stain the mitochondria and lysosomes of living cells, respectively, which exhibited an improved PDT effect compared to theLysosome-targeted complex, especially under hypoxia conditions, suggestive of a higher practicable potential of mitochondria- targeted PDT agents in cancer therapy.